ANIP  valuation analysis

Basics
Name: ANI Pharmaceuticals, Inc
Description: ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Mar 09, 2021
Market cap: $416.71M (1373rd)
Sales(TTM): $208.47M (1353rd)
Earnings(TTM): -$22.55M (1098th)

Value
FFER: 0.68 (why)
Actual price: $33.70
FFEThis is ANI Pharmaceuticals, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $47.86
Quantile: ANIP is very cheap given its fundamentals.
Prices as of EOD 2021-04-14
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • ANI Pharmaceuticals, Inc's earnings decreased from $6.09M to -$22.55M in the last year.
  • ANI Pharmaceuticals, Inc's operating income decreased from $16.35M to -$16.02M in the last year.
Earnings / MarketCap
ANI Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
ANI Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
ANI Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
ANI Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry